NASDAQ : NTRB
Nutriband Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 6.64 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 80.71M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Nutriband Inc. (NTRB) reported revenue of 1.62M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year February - January; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 1.62M | 2.04M | 2.14M | 2.09M | 2.08M | 1.42M |
| Cost of Revenue | 1.08M | 1.47M | 1.40M | 1.22M | 1.33M | 917.84K |
| Gross Profit | 536.12K | 566.31K | 743.32K | 862.11K | 750.41K | 504.31K |
| Selling, General & Admin | 6.37M | 6.99M | 4.31M | 3.77M | 3.92M | 4.02M |
| Research & Development | 1.21M | 1.89M | 3.12M | 1.96M | 982.23K | 411.38K |
| Operating Expenses | 7.58M | 8.88M | 7.43M | 5.73M | 4.90M | 4.43M |
| Operating Income | -7.05M | -8.32M | -6.69M | -4.87M | -4.15M | -3.93M |
| Interest Expense | -27.57K | -22.54K | -21.41K | -75.81K | -8.29K | -118.42K |
| Interest & Investment Income | 16.85K | |||||
| Other Non Operating Income (Expenses) | 110.86K | 110.86K | 191.67K | |||
| EBT Excluding Unusual Items | -6.96M | -8.23M | -6.52M | -4.93M | -4.16M | -4.05M |
| Impairment of Goodwill | -3.60M | -327.33K | -2.18M | |||
| Other Unusual Items | -368.04K | -554.42K | 53.03K | |||
| Pretax Income | -6.96M | -8.23M | -10.48M | -5.49M | -4.48M | -6.18M |
| Net Income | -6.96M | -8.23M | -10.48M | -5.49M | -4.48M | -6.18M |
| Preferred Dividends & Other Adjustments | 21.81M | 196.59K | ||||
| Net Income to Common | -6.96M | -30.04M | -10.48M | -5.49M | -4.48M | -6.37M |
| Shares Outstanding (Basic) | 12.13M | 11.64M | 10.61M | 7.95M | 8.46M | 7.93M |
| Shares Outstanding (Diluted) | 12.13M | 11.64M | 10.61M | 7.95M | 8.46M | 7.93M |
| EPS (Basic) | -0.57 | -2.58 | -0.99 | -0.69 | -0.53 | -0.80 |
| EPS (Diluted) | -0.57 | -2.58 | -0.99 | -0.69 | -0.53 | -0.80 |
| Free Cash Flow | -3.63M | -5.14M | -4.72M | -3.58M | -3.07M | -2.89M |
| Free Cash Flow Per Share | -0.30 | -0.44 | -0.45 | -0.45 | -0.36 | -0.36 |
| Gross Margin | 33.14% | 27.81% | 34.74% | 41.34% | 36.08% | 35.46% |
| Operating Margin | -435.58% | -408.41% | -312.67% | -233.63% | -199.45% | -276.33% |
| Profit Margin | -430.43% | -1,475.16% | -489.95% | -263.05% | -215.59% | -448.10% |
| Free Cash Flow Margin | -224.54% | -252.37% | -220.54% | -171.64% | -147.46% | -203.27% |
| EBITDA | -6.90M | -8.12M | -6.40M | -4.58M | -3.82M | -3.62M |
| EBITDA Margin | -299.34% | -219.83% | -183.58% | -254.62% | ||
| D&A For EBITDA | 146.44K | 193.80K | 285.05K | 287.72K | 330.14K | 308.74K |
| EBIT | -7.05M | -8.32M | -6.69M | -4.87M | -4.15M | -3.93M |
| EBIT Margin | -233.63% | -199.45% | -276.33% |
Balance sheet
Fiscal year February - January; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.42M | 4.57M | 4.31M | 492.94K | 1.99M | 4.89M |
| Cash & Short-Term Investments | 3.42M | 4.57M | 4.31M | 492.94K | 1.99M | 4.89M |
| Accounts Receivable | 23.59K | 118.40K | 73.85K | 148.65K | 113.05K | 71.38K |
| Receivables | 23.59K | 118.40K | 73.85K | 148.65K | 113.05K | 71.38K |
| Inventory | 170.73K | 117.99K | 212.04K | 168.60K | 229.34K | 131.65K |
| Prepaid Expenses | 203.44K | 177.47K | 196.66K | 211.67K | 365.93K | 370.47K |
| Total Current Assets | 3.82M | 4.99M | 4.79M | 1.02M | 2.69M | 5.47M |
| Property, Plant & Equipment | 584.09K | 639.25K | 695.06K | 806.30K | 960.49K | 998.34K |
| Goodwill | 1.72M | 1.72M | 1.72M | 5.02M | 5.02M | 5.35M |
| Other Intangible Assets | 170.09K | 200.43K | 261.09K | 667.28K | 780.43K | 926.91K |
| Total Assets | 6.29M | 7.55M | 7.47M | 7.52M | 9.46M | 12.74M |
| Accounts Payable | 644.52K | 502.65K | 698.82K | 680.13K | 534.68K | 639.54K |
| Current Portion of Long-Term Debt | 128.44K | 128.87K | 128.14K | 127.18K | 19.74K | 14.12K |
| Current Portion of Leases | 33.97K | 32.45K | 34.28K | 31.29K | 19.33K | |
| Current Unearned Revenue | 100.12K | 120.30K | 155.88K | 157.50K | 162.90K | 106.27K |
| Total Current Liabilities | 907.05K | 784.28K | 982.85K | 999.09K | 748.61K | 779.26K |
| Long-Term Debt | 25.10K | 35.86K | 58.20K | 79.83K | 100.50K | 101.12K |
| Long-Term Leases | 32.21K | 48.30K | 34.28K | |||
| Total Liabilities | 964.36K | 868.45K | 1.04M | 1.08M | 883.39K | 880.38K |
| Common Stock | 12.16K | 12.16K | 11.07K | 8.86K | 7.83K | 9.15K |
| Additional Paid-In Capital | 54.22M | 53.44M | 45.03M | 34.44M | 31.09M | 29.97M |
| Retained Earnings | -48.81M | -46.69M | -38.46M | -27.98M | -22.49M | -18.01M |
| Treasury Stock | -87.91K | -86.85K | -148.55K | -32.64K | -32.64K | -104.47K |
| Comprehensive Income & Other | -304.00 | -304.00 | -304.00 | -304.00 | -304.00 | -304.00 |
| Total Common Equity | 5.33M | 6.68M | 6.43M | 6.44M | 8.57M | 11.86M |
| Shareholders' Equity | 5.33M | 6.68M | 6.43M | 6.44M | 8.57M | 11.86M |
| Total Liabilities & Equity | 6.29M | 7.55M | 7.47M | 7.52M | 9.46M | 12.74M |
| Total Debt | 219.72K | 245.49K | 186.35K | 241.28K | 185.81K | 134.57K |
| Net Cash (Debt) | 3.20M | 4.33M | 4.13M | 251.66K | 1.80M | 4.76M |
| Net Cash Per Share | 0.26 | 0.37 | 0.39 | 0.03 | 0.21 | 0.60 |
| Filing Date Shares Outstanding | 12.16M | 12.16M | 11.12M | 10.96M | 7.83M | 9.12M |
| Total Common Shares Outstanding | 12.16M | 12.16M | 11.07M | 8.86M | 7.83M | 9.15M |
| Working Capital | 2.91M | 4.20M | 3.81M | 22.77K | 1.95M | 4.69M |
| Book Value Per Share | 0.44 | 0.55 | 0.58 | 0.73 | 1.09 | 1.30 |
| Tangible Book Value | 3.44M | 4.76M | 4.45M | 749.24K | 2.77M | 5.58M |
| Tangible Book Value Per Share | 0.28 | 0.39 | 0.40 | 0.08 | 0.35 | 0.61 |
| Machinery | 1.55M | 1.55M | 1.55M | 1.46M | 1.40M | 1.30M |
Cash flow statement
Fiscal year February - January; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -6.96M | -8.23M | -10.48M | -5.49M | -4.48M | -6.18M |
| Depreciation & Amortization | 146.44K | 193.80K | 285.05K | 287.72K | 330.14K | 318.26K |
| Other Amortization | 97.48K | |||||
| Asset Writedown & Restructuring Costs | 3.60M | 327.33K | 2.18M | |||
| Stock-Based Compensation | 3.41M | 2.74M | 1.54M | 742.70K | 845.28K | 1.36M |
| Provision & Write-off of Bad Debts | 118.36K | |||||
| Other Operating Activities | 36.00K | 36.00K | 399.41K | 585.80K | 212.84K | -53.03K |
| Change in Accounts Receivable | 137.21K | -44.56K | 74.80K | -153.97K | -41.66K | 42.97K |
| Change in Inventory | -32.70K | 94.05K | -43.44K | 60.73K | -97.69K | -78.80K |
| Change in Accounts Payable | -431.23K | 120.94K | 23.61K | 198.89K | -104.86K | -145.26K |
| Change in Unearned Revenue | 80.70K | -35.58K | -1.62K | -5.40K | 56.64K | 19.42K |
| Change in Other Net Operating Assets | -12.72K | -8.05K | -19.27K | 122.97K | -31.74K | -379.71K |
| Operating Cash Flow | -3.63M | -5.13M | -4.63M | -3.53M | -2.99M | -2.81M |
| Capital Expenditures | -5.32K | -92.04K | -51.76K | -79.30K | -81.59K | |
| Investing Cash Flow | -5.32K | -92.04K | -51.76K | -79.30K | -81.59K | |
| Short-Term Debt Issued | 300.00K | 2.11M | ||||
| Total Debt Issued | 300.00K | 2.11M | ||||
| Short-Term Debt Repaid | -1.50M | |||||
| Long-Term Debt Repaid | -21.62K | -20.66K | -19.76K | -17.80K | -127.04K | |
| Total Debt Repaid | -15.01K | -21.62K | -20.66K | -19.76K | -17.80K | -1.63M |
| Net Debt Issued (Repaid) | -15.01K | -21.62K | 279.34K | 2.09M | -17.80K | -1.63M |
| Issuance of Common Stock | 75.00K | 5.42M | 8.41M | 296.88K | 9.36M | |
| Repurchase of Common Stock | -1.06K | -148.55K | -119.01K | -104.47K | ||
| Financing Cash Flow | 58.93K | 5.40M | 8.54M | 2.09M | 160.07K | 7.63M |
| Net Cash Flow | -3.57M | 263.14K | 3.82M | -1.49M | -2.91M | 4.74M |
| Free Cash Flow | -3.63M | -5.14M | -4.72M | -3.58M | -3.07M | -2.89M |
| Free Cash Flow Margin | -224.54% | -252.37% | -220.54% | -171.64% | -147.46% | -203.27% |
| Free Cash Flow Per Share | -0.30 | -0.44 | -0.45 | -0.45 | -0.36 | -0.36 |
| Levered Free Cash Flow | -1.41M | -2.45M | -2.40M | -1.79M | -1.68M | -1.52M |
| Unlevered Free Cash Flow | -1.39M | -2.43M | -2.38M | -1.75M | -1.68M | -1.55M |
| Cash Interest Paid | 1.25K | 1.25K | 5.63K | 7.35K | 4.27K | 18.60K |
| Change in Working Capital | -258.74K | 126.81K | 34.09K | 223.22K | -219.32K | -541.38K |
Ratios
Fiscal year February - January; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 76.58M | 58.23M | 92.07M | 22.08M | 28.59M | 33.97M |
| Enterprise Value | 73.38M | 53.18M | 86.57M | 23.07M | 25.97M | 28.71M |
| Last Close Price | 6.30 | 4.79 | 8.29 | 2.61 | 3.65 | 3.75 |
| Forward PE | 13.72 | 299.96 | 299.96 | 299.96 | 299.96 | |
| PS Ratio | 47.34 | 28.59 | 43.03 | 10.59 | 13.75 | 23.89 |
| PB Ratio | 14.38 | 8.72 | 14.32 | 3.43 | 3.33 | 2.87 |
| P/TBV Ratio | 22.29 | 12.24 | 20.70 | 29.47 | 10.32 | 6.08 |
| EV/Sales Ratio | 45.36 | 26.11 | 40.46 | 11.06 | 12.49 | 20.19 |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.03 | 0.04 | 0.02 | 0.01 |
| Net Debt / Equity Ratio | -0.60 | -0.65 | -0.64 | -0.04 | -0.21 | -0.40 |
| Net Debt / EBITDA Ratio | 0.46 | 0.53 | 0.64 | 0.06 | 0.47 | 1.31 |
| Net Debt / FCF Ratio | 0.88 | 0.84 | 0.87 | 0.07 | 0.59 | 1.65 |
| Asset Turnover | 0.20 | 0.27 | 0.29 | 0.25 | 0.19 | 0.12 |
| Inventory Turnover | 7.01 | 8.91 | 7.34 | 6.15 | 7.36 | 9.95 |
| Quick Ratio | 3.80 | 5.98 | 4.46 | 0.64 | 2.80 | 6.37 |
| Current Ratio | 4.21 | 6.36 | 4.88 | 1.02 | 3.60 | 7.01 |
| Return on Equity (ROE) | -100.75% | -125.56% | -162.94% | -73.08% | -43.89% | -65.11% |
| Return on Assets (ROA) | -53.48% | -69.23% | -55.79% | -35.88% | -23.36% | -21.67% |
| Return on Capital Employed (ROCE) | -130.80% | -123.00% | -103.10% | -74.70% | -47.60% | -32.90% |
| Earnings Yield | -9.11% | -14.13% | -11.39% | -24.84% | -15.68% | -18.18% |
| FCF Yield | -4.74% | -8.83% | -5.12% | -16.21% | -10.72% | -8.51% |
| Buyback Yield / Dilution | -8.93% | -9.74% | -33.36% | 5.97% | -6.64% | -17.82% |